Treatment of Vitiligo with Autologous Cell Suspension A study “treatment of
autologous-cell-suspension
Vitiligo with Autologous cell Suspension” was published in Journal Watch dermatology, October 27, 2004. This research was held in India. It was the study of segmented Vitiligo and focal Vitiligo treated by cell suspension with melanocytes and Keratenocytes cell transplantation. Using cell suspension with non cultured melanocytes which is injected into the blister of depigmented lesions, gave 85% positive response in the form of regimentation.
Dermatologists transplanted the autologous cell suspension into lesions of 49 cases of segmental Vitiligo and 25 of focal Vitiligo. The results were 84% of the studied cases of segmental Vitiligo and 73% of focal Vitiligo. And during the following 5 years, there has not been seen loss of pigments. It is very useful and simpler technique than UV phototherapy and transplant of cultured melanocytes. But it is sophisticated research to be done outside the major hospital setup. A hospital with sophisticated lab is very significant for the isolation of cell suspension.
People With Vitiligo